Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Envoy Medical announced that all 56 subjects in its pivotal trial of the fully implanted Acclaim cochlear implant have completed their activation visits. This milestone provides increased confidence in the study timeline, allowing the scheduling of remaining 12-month follow-up visits ahead of data analysis and PMA submission.
Key figures
- Drug Name
- Acclaim® cochlear implant
- Phase Of Trial
- pivotal clinical trial
- Subjects enrolled
- 56
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.